Mass screening of 100,000 babies aims to catch rare diseases at birth
NCT ID NCT04393701
Summary
This study aims to screen 100,000 newborns in France for two rare genetic disorders (MPS I and Pompe disease) using a simple blood spot test. The goal is to understand how common these diseases are and to detect them early, when treatment may be most effective. Participation is voluntary and involves parents giving consent for their newborn's standard screening blood sample to also be tested for these specific conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SCREENING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caen University Hospital
RECRUITINGCaen, France
Contact
-
Rouen University Hospital
RECRUITINGRouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.